Mettler Toledo reported $4.13B of revenue over the trailing twelve months, +6.9% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.13B (to Q2 2026). Net income: $906M, trailing twelve months to Q2 2026. Free cash flow: $864M, trailing twelve months to Q2 2026. EPS: $44.38, trailing twelve months to Q2 2026.

MTDMettler Toledo

Healthcare

$1,550.83+20% 1Y

$1,550.83

$1.0K52 weeks$1.6K

Latest close: a new 52-week highOct 9, 2026what changed →

MTD as reported

Mettler Toledo reported $4.13B of revenue over the trailing twelve months, +6.9% on the year before. 9 reported series are charted on this page, each one as filed.

$4.13B

Revenue, trailing twelve months · to Q2 2026 · +6.9% against the twelve months before

Net income: $906M
Net income · +9.1% year on year · trailing twelve months to Q2 2026
Free cash flow: $864M
Free cash flow · +1.9% year on year · trailing twelve months to Q2 2026
EPS: $44.38
EPS · +12% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for MTD, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.13B	+6.9%	Q2 2026
Net income	$906M	+9.1%	Q2 2026
EPS	$44.38	+12%	Q2 2026
Gross margin	60%	n/a	Q2 2026
Net margin	22%	n/a	Q2 2026
ROE	240%	n/a	Q2 2026
ROA	24%	n/a	Q2 2026
Free cash flow	$864M	+1.9%	Q2 2026
P/E	34.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.